electroCore (ECOR) Share-based Compensation Growth (1y) (2018 - 2026)
electroCore (ECOR) Share-based Compensation Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.69% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 37.62% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 12.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 12.94% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -30.44% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 59.09% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | electroCore | 56,941.08 | -8.77 Mn | 8.36 Mn | 307.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307.41% |
| Dec 31, 2025 | -8.56% |
| Sep 30, 2025 | 3.75% |
| Jun 30, 2025 | 344.92% |
| Mar 31, 2025 | 11.57% |
| Dec 31, 2024 | 28.50% |
| Sep 30, 2024 | -26.34% |
| Jun 30, 2024 | 157.92% |
| Mar 31, 2024 | -15.38% |
| Dec 31, 2023 | -31.86% |
| Sep 30, 2023 | -4.06% |
| Jun 30, 2023 | -75.66% |
| Mar 31, 2023 | -26.38% |
| Dec 31, 2022 | -79.77% |
| Sep 30, 2022 | -25.53% |
| Jun 30, 2022 | -10.26% |
| Mar 31, 2022 | -17.52% |
| Dec 31, 2021 | 274.08% |
| Sep 30, 2021 | 2.30% |
| Jun 30, 2021 | 455,334.78% |